tiprankstipranks
Addex Therapeutics (ADXN)
NASDAQ:ADXN
US Market
ADXN
Addex Therapeutics
RESEARCH TOOLSreports
Want to see ADXN full AI Analyst Report?

Addex Therapeutics (ADXN) Ratios

82 Followers

Addex Therapeutics Ratios

ADXN's free cash flow for Q4 2025 was CHF0.87. For the 2025 fiscal year, ADXN's free cash flow was decreased by CHF and operating cash flow was CHF-49.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 1.40 1.40 4.42 1.46 2.39
Quick Ratio
 1.40 1.40 4.42 1.46 2.39
Cash Ratio
 1.37 1.37 4.17 1.34 2.12
Solvency Ratio
 -4.21 -5.06 7.31 -2.93 -6.08
Operating Cash Flow Ratio
 -1.81 -1.73 -6.70 -2.76 -5.01
Short-Term Operating Cash Flow Coverage
 -282.77 -270.01 0.00 0.00 0.00
Net Current Asset Value
CHF 77.41KCHF 77.50KCHF 2.54MCHF 738.18KCHF 4.46M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.07 0.05
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.30 0.08
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.23 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.34 1.10 4.05 1.69
Debt Service Coverage Ratio
 -244.00 -318.67 -1.31K -101.37 -213.77
Interest Coverage Ratio
 -175.91 -1.16K -776.78 -103.81 -215.57
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 0.04 0.06 0.59 1.12
Net Debt to EBITDA
 0.28 0.48 0.71 1.61 0.63
Profitability Margins
Gross Profit Margin
-4.78%95.10%100.00%100.00%100.00%
EBIT Margin
-3782.37%-1628.25%-1214.00%-154.77%-757.57%
EBITDA Margin
-3776.83%-1623.35%-1149.63%-135.80%-734.86%
Operating Profit Margin
-1839.80%-1628.25%-681.82%-139.06%-741.04%
Pretax Profit Margin
-4472.75%-3958.46%-1214.88%-155.00%-759.54%
Net Profit Margin
-4398.50%-3892.31%1746.04%-654.47%-1462.57%
Continuous Operations Profit Margin
-4472.75%-3958.46%-1214.88%-155.00%-759.54%
Net Income Per EBT
98.34%98.33%-143.72%422.22%192.56%
EBT Per EBIT
243.11%243.11%178.18%111.47%102.50%
Return on Assets (ROA)
-105.82%-127.26%66.08%-227.41%-251.20%
Return on Equity (ROE)
-102.62%-169.95%72.91%-921.57%-423.46%
Return on Capital Employed (ROCE)
-54.54%-65.60%-27.90%-128.27%-210.82%
Return on Invested Capital (ROIC)
-54.46%-65.51%-27.88%-110.90%-199.41%
Return on Tangible Assets
-105.82%-127.26%66.08%-227.41%-251.20%
Earnings Yield
-104.96%-141.51%135.81%-335.14%-474.49%
Efficiency Ratios
Receivables Turnover
 7.62 10.35 26.05 10.66 2.38
Payables Turnover
 0.26 0.02 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 4.47 6.07 9.46 4.57 3.57
Asset Turnover
 0.02 0.03 0.04 0.35 0.17
Working Capital Turnover Ratio
 0.18 0.13 0.20 0.55 0.13
Cash Conversion Cycle
 -1.34K -21.56K 14.01 34.23 153.53
Days of Sales Outstanding
 47.92 35.26 14.01 34.23 153.53
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 1.39K 21.60K 0.00 0.00 0.00
Operating Cycle
 47.92 35.26 14.01 34.23 153.53
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -2.22 -6.57 -12.91 -43.65
Free Cash Flow Per Share
 -0.02 -2.22 -6.57 -12.92 -43.65
CapEx Per Share
 0.00 0.00 <0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -4.22K -1.17K -28.29K
Capital Expenditure Coverage Ratio
 0.00 0.00 -4.22K -1.17K -28.29K
Operating Cash Flow Coverage Ratio
 -62.61 -59.78 -127.96 -23.21 -44.05
Operating Cash Flow to Sales Ratio
 -14.20 -9.97 -13.30 -4.96 -11.56
Free Cash Flow Yield
-31.77%-36.26%-103.46%-253.96%-374.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.95 -0.71 0.74 -0.30 -0.21
Price-to-Sales (P/S) Ratio
 44.68 27.51 12.86 1.95 3.08
Price-to-Book (P/B) Ratio
 1.35 1.20 0.54 2.75 0.89
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.15 -2.76 -0.97 -0.39 -0.27
Price-to-Operating Cash Flow Ratio
 -2.95 -2.76 -0.97 -0.39 -0.27
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 >-0.01 <0.01 -0.09
Price-to-Fair Value
 1.35 1.20 0.54 2.75 0.89
Enterprise Value Multiple
 -0.91 -1.22 -0.41 0.17 0.21
Enterprise Value
 5.23M 4.12M 1.90M -371.37K -2.20M
EV to EBITDA
 -0.91 -1.22 -0.41 0.17 0.21
EV to Sales
 34.20 19.79 4.69 -0.23 -1.55
EV to Free Cash Flow
 -2.41 -1.98 -0.35 0.05 0.13
EV to Operating Cash Flow
 -2.41 -1.98 -0.35 0.05 0.13
Tangible Book Value Per Share
 0.03 5.10 11.84 1.85 13.05
Shareholders’ Equity Per Share
 0.03 5.10 11.84 1.85 13.05
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 0.22 0.49 2.60 3.78
Net Income Per Share
 -0.05 -8.66 8.63 -17.05 -55.25
Tax Burden
 0.98 0.98 -1.44 4.22 1.93
Interest Burden
 1.18 2.43 1.00 1.00 1.00
Research & Development to Revenue
 1.22 3.89 1.08 0.58 5.54
SG&A to Revenue
 13.48 13.35 4.15 1.26 2.29
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 1.11 2.59
Income Quality
 0.32 0.32 -0.76 0.76 0.79
Currency in CHF